Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCV5X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $100,228
Award facts
- Contract value 100% obligated
- $100,227.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $100,227.87 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens under a firm fixed price contract. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation and represents a competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Dupixent is a biologic immunosuppressant medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis, making this order consistent with the contractor's portfolio of specialty pharmaceutical products delivered to Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCV5X?
SPE2DR26FCV5X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FCV5X worth?
The government has obligated $100,228 on SPE2DR26FCV5X.
Is contract SPE2DR26FCV5X an order under another contract?
Yes. SPE2DR26FCV5X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV5X competed?
The extent of competition for SPE2DR26FCV5X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award